InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in InflaRx N.V. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −1 vs. Q2 2021
- Shares held
- 8.88M
- −2.11M (−19.2%) vs. Q2 2021
- Total value
- $23.0M
- −$9.64M (−29.5%) vs. Q2 2021
- New holders
- 6
- 5 more added
- Sold out
- 7
- 11 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IFRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 62 | $211.6M |
| Q1 2026 | 35 | $16.9M |
| Q4 2025 | 34 | $19.6M |
| Q3 2025 | 27 | $24.9M |
| Q2 2025 | 27 | $13.3M |
| Q1 2025 | 31 | $17.9M |
| Q4 2024 | 30 | $32.1M |
| Q3 2024 | 27 | $19.7M |
| Q2 2024 | 33 | $23.0M |
| Q1 2024 | 37 | $21.3M |
| Q4 2023 | 39 | $27.8M |
| Q3 2023 | 42 | $56.8M |
| Q2 2023 | 37 | $82.7M |
| Q1 2023 | 25 | $7.08M |
| Q4 2022 | 33 | $11.6M |
| Q3 2022 | 30 | $10.5M |
| Q2 2022 | 27 | $7.63M |
| Q1 2022 | 32 | $12.0M |
| Q4 2021 | 38 | $44.1M |
| Q3 2021 | 35 | $23.0M |
| Q2 2021 | 37 | $33.1M |
| Q1 2021 | 42 | $56.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding InflaRx N.V.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 3,285,000 | $8.51M | 0.14% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,064,118 | $2.76M | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 722,975 | $1.87M | 0.00% | −28,318−3.8% | Reduced |
| Ikarian Capital, LLC | 631,048 | $1.63M | 0.37% | −35,548−5.3% | Reduced |
| DAFNA Capital Management LLC | 600,000 | $1.55M | 0.41% | 00.0% | Unchanged |
| Great Point Partners LLC | 551,918 | $1.43M | 0.34% | −1,648,082−74.9% | Reduced |
| Laurion Capital Management LP | 500,000 | $1.29M | 0.02% | 00.0% | Unchanged |
| Kingdon Capital Management, L.L.C. | 400,000 | $1.04M | 0.18% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 318,000 | $823.0K | 0.38% | −25,000−7.3% | Reduced |
| Bank Julius Baer & Co. Ltd, Zurich | 197,607 | $512.0K | 0.00% | −360.0% | Reduced |
| Renaissance Technologies LLC | 83,090 | $215.0K | 0.00% | −51,193−38.1% | Reduced |
| Franklin Street Advisors Inc | 75,100 | $195.0K | 0.02% | 00.0% | Unchanged |
| Birchview Capital, LP | 70,000 | $181.0K | 0.12% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 63,341 | $164.0K | 0.01% | −21,559−25.4% | Reduced |
| Millennium Management LLC | 46,080 | $119.0K | 0.00% | +13,538+41.6% | Added |
| Susquehanna International Group, LLP | 37,517 | $97.0K | 0.00% | +3,853+11.4% | Added |
| Marquette Asset Management, LLC | 33,215 | $86.0K | 0.02% | 00.0% | Unchanged |
| IPG Investment Advisors LLC | 25,900 | $67.1K | 0.02% | 00.0% | Unchanged |
| Virtu Financial LLC | 26,016 | $67.0K | 0.01% | +26,016 | New |
| Two Sigma Securities, LLC | 22,553 | $58.0K | 0.01% | +22,553 | New |
| Pacifica Partners Inc. | 20,585 | $55.0K | 0.04% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 18,991 | $49.0K | 0.00% | +18,991 | New |
| ETF Managers Group, LLC | 16,134 | $42.0K | 0.00% | +3,203+24.8% | Added |
| Raymond James Financial Services Advisors, Inc. | 13,888 | $36.0K | 0.00% | −9,458−40.5% | Reduced |
| Two Sigma Investments, LP | 11,070 | $29.0K | 0.00% | +11,070 | New |
| Raymond James & Associates | 10,419 | $27.0K | 0.00% | −9,500−47.7% | Reduced |
| Occudo Quantitative Strategies LP | 10,548 | $27.0K | 0.00% | −214−2.0% | Reduced |
| BlackRock Inc. | 7,419 | $19.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,015 | $13.0K | 0.00% | +3,770+302.8% | Added |
| Steward Partners Investment Advisory, LLC | 4,800 | $12.0K | 0.00% | +3,600+300.0% | Added |
| Simplex Trading, LLC | 3,846 | $11.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 609 | $2.00K | 0.00% | +609 | New |
| Royal Bank of Canada | 776 | $2.00K | 0.00% | +776 | New |
| Harbour Investments, Inc. | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2 | $0 | 0.00% | −28−93.3% | Reduced |
| Altium Capital Management LP | 0 | $0 | 0.00% | −161,206−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −85,761−100.0% | Sold out |
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 0 | $0 | 0.00% | −49,800−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −46,633−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −23,010−100.0% | Sold out |
| Personal Cfo Solutions, LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −10,836−100.0% | Sold out |
| QS Investors, LLC | – | – | – | – | Not filed |